Shares of Theravance Inc. (NASDAQ: THRX) rallied on Monday after a report from the U.S. drug regulators showed that the once-a-day lung disease treatment Breo Ellipta, which the company is developing in conjunction with the GlaxoSmithKline Plc, might get an approval.
Continue reading Major Movers on April 15; THRX, ACOR, LIFE, TMO, NGD, ABX, GG, WLT, S
Shares of Life Technologies Corp. (NASDAQ:LIFE) rallied on Friday. According to a report carried on Financial Post newspaper, the gene sequencing company has appointed Deutsche Bank AG and Moelis & Co for a strategic review, which could possibly result in company going private through a leveraged buyout (LB) or being acquired by larger industry players.
Continue reading Major Movers on January 18; LIFE, COF, INTC, MS, GE